2012 ICD-9-CM Diagnosis Code V58.11. Encounter for antineoplastic chemotherapy. Short description: Antineoplastic chemo enc. ICD-9-CM V58.11 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, V58.11 should only be used for claims with a date of service on or before September 30, 2015.
The CPT codes for chemotherapy include – 96360 – Intravenous infusion, hydration; initial, 31 minutes to 1 hour 96361 – Intravenous infusion, hydration; each additional hour 96365 – Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
838 Chemotherapy with acute leukemia as secondary diagnosis with cc or high dose chemotherapy agent Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
If a patient is admitted only to receive chemotherapy, sequence code V58.11 as the principal diagnosis. Sequence the malignancy (primary or secondary) as the principal diagnosis if a patient is admitted for staging the malignancy or a procedure such as thoracentesis even though chemotherapy may be administered.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Report ICD-10 code Z01. 818, Encounter for other preprocedural examination (is defined as Encounter for preprocedural examination NOS and Encounter for examinations prior to antineoplastic chemotherapy), when the test is performed as a baseline study before chemotherapy. List Z01. 818 as your primary diagnosis code.
ICD-9-CM Diagnosis Code 199.1 : Other malignant neoplasm without specification of site.
2022 ICD-10-CM Diagnosis Code Z51. 11: Encounter for antineoplastic chemotherapy.
Code 96413 (chemotherapy administration, intravenous infusion technique; up to one hour, single or initial substance/drug) would be used to report the first 90 minutes of the infusion.
Background: Chemotherapy administration services (CPT codes 96400, 96408 to 96425, 96520 and 96530) , therapeutic or diagnostic infusions (excluding chemotherapy) (CPT codes 90780 to 90781), and drug injection codes (90782 to 90788) are paid under the Medicare physician fee schedule.
Code C80. 1, Malignant (primary) neoplasm, unspecified, equates to Cancer, unspecified.
A malignant neoplasm (NEE-oh-plaz-um) is another term for a cancerous tumor. The term “neoplasm” refers to an abnormal growth of tissue. The term “malignant” means the tumor is cancerous and is likely to spread (metastasize) beyond its point of origin.
ICD-9-CM Diagnosis Code 202.8 : Other malignant lymphomas.
11, Encounter for antineoplastic chemotherapy; or Z51. 12, encounter of antineoplastic immunotherapy as the first-listed or principal diagnosis.
Treatment given to cure the cancer, such as chemotherapy or radiation therapy. This does not include long-term treatment such as hormone medication, which may be taken for several years to maintain remission.
ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter T45. 1X5A.
If a patient is admitted only to receive chemotherapy, sequence code V58.11 as the principal diagnosis. Sequence the malignancy (primary or secondary) as the principal diagnosis if a patient is admitted for staging the malignancy or a procedure such as thoracentesis even though chemotherapy may be administered.
Sequence dehydration as the principal diagnosis when the admission is for managing dehydration due to the malignancy or the therapy and only the dehydration is being treated. Sequence the malignancy as the principal diagnosis when a patient is admitted for surgical removal of a malignancy followed by chemotherapy.
Chemotherapy uses powerful drugs in an attempt to eliminate cancer cells in the body. However, it also kills other fast-growing cells such as hair and blood cells, causing side effects such as hair loss and anemia.
Assign 285.22, Anemia in neoplastic disease, for anemia due to malignancy. Antineoplastic-chemotherapy-induced anemia is classified to 285.3. Do not use 285.22 for anemia due to chemotherapy. Also, it is unnecessary to assign E933.1, Antineoplastic and immunosuppressive drug, along with 285.3 since the adverse effect of chemotherapy information is ...
Z79.02 Long term (current) use of antithrombotics/antiplatelets. Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) Z79.2 Long term (current) use of antibiotics. Z79.3 Long term (current) use of hormonal contraceptives. Z79.4 Long term (current) use of insulin.
Long term (current) drug therapy Z79- 1 drug abuse and dependence (#N#ICD-10-CM Diagnosis Code F11#N#Opioid related disorders#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#F11 -#N#ICD-10-CM Diagnosis Code F19#N#Other psychoactive substance related disorders#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Includes#N#polysubstance drug use (indiscriminate drug use)#N#F19) 2 drug use complicating pregnancy, childbirth, and the puerperium (#N#ICD-10-CM Diagnosis Code O99.32#N#Drug use complicating pregnancy, childbirth, and the puerperium#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Use Additional#N#code (s) from F11 - F16 and F18 - F19 to identify manifestations of the drug use#N#O99.32-)
A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code ( Z79) and the excluded code together. drug abuse and dependence (.